Biopharmaceuticals
Licensing
News Release - December 20, 2006
Kosan Announces License of Motilin Agonist Program to Pfizer
Source: Kosan Biosciences
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.